Effect of dendritic cells (DC) vaccination on immunological parameters in patients with metastatic melanoma

被引：0
|
作者：
Casamassima, Addolorata
Candeloro, Antonella
Scelsi, Michele
Morelli, Valentina
Lamacchia, Pasqua
Napoli, Luca
D'Agnelli, Maria Cosima
Quaranta, Michele
Guida, Michele
机构：
[1] Inst Oncol, Expt Oncol Lab, Bari, Italy
[2] Osped San Paolo, Bari, Italy
来源：
JOURNAL OF IMMUNOTHERAPY | 2006年 / 29卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：645 / 645
页数：1
相关论文
共 50 条
  • [41] Vaccination of B-CLL patients with autologous dendritic cells results in immunological and clinical responses
    Hus, Iwona
    Schmitt, Michael
    Tabarkiewicz, Jacek
    Radej, Sebastian
    Bojarska-Junak, Agnieszka
    Wojas, Kamila
    Schmitt, Anita
    Giannopoulos, Krzysztof
    Dmoszynska, Anna
    Rolinski, Jacek
    BLOOD, 2007, 110 (11) : 611A - 611A
  • [42] Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
    Titzer, S
    Christensen, O
    Manzke, O
    Tesch, H
    Wolf, J
    Emmerich, B
    Carsten, C
    Diehl, V
    Bohlen, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 805 - 816
  • [43] The treatment of patients with disseminated malignant melanoma by vaccination with autologous cell hybrids of tumor cells and dendritic cells
    Krause, SW
    Neumann, T
    Soruri, A
    Mayer, S
    Peters, JH
    Andreesen, R
    JOURNAL OF IMMUNOTHERAPY, 2002, 25 (05) : 421 - 428
  • [44] Dendritic cell vaccination in metastatic melanoma (MM) and renal cell carcinoma (RCC)
    Guida, M.
    Casamassima, A.
    Candeloro, A.
    Scelsi, M.
    Montemurro, S.
    Zito, A.
    Misino, A.
    Morelli, V
    Napoli, L.
    Quaranta, M.
    ANNALS OF ONCOLOGY, 2006, 17 : XI60 - XI60
  • [45] Dendritic cell vaccination in metastatic melanoma (MM) and renal cell carcinoma (RCC)
    Guida, M.
    Casamassima, A.
    Candeloro, A.
    Scelsi, M.
    Montemurro, S.
    Zito, A.
    Misino, A.
    Morelli, V.
    Napoli, L.
    Quaranta, M.
    ANNALS OF ONCOLOGY, 2006, 17 : VII158 - VII159
  • [46] Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
    de Rosa, Francesco
    Ridolfi, Laura
    Fiammenghi, Laura
    Petrini, Massimiliano
    Granato, Anna M.
    Ancarani, Valentina
    Pancisi, Elena
    Soldati, Valentina
    Cassan, Serena
    Bulgarelli, Jenny
    Framarini, Massimo
    Tauceri, Francesca
    Migliori, Giuseppe
    Brolli, Claudia
    Gentili, Giorgia
    Petracci, Elisabetta
    Nanni, Oriana
    Riccobon, Angela
    Ridolfi, Ruggero
    Guidoboni, Massimo
    MELANOMA RESEARCH, 2017, 27 (04) : 351 - 357
  • [47] Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells
    Uslu, Ugur
    Schliep, Stefan
    Schliep, Klaus
    Erdmann, Michael
    Koch, Hans-Uwe
    Parsch, Hans
    Rosenheinrich, Stina
    Anzengruber, Doris
    Bosserhoff, Anja Katrin
    Schuler, Gerold
    Schuler-Thurner, Beatrice
    ANTICANCER RESEARCH, 2017, 37 (09) : 5033 - 5037
  • [48] Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells
    Fay, J. W.
    Banchereau, J.
    Palucka, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Long-term survival in patients with metastatic melanoma vaccinated with melanoma-antigen loaded dendritic cells
    Fay, J. W.
    Banchereau, J. F.
    Palucka, A. K.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 894 - 894
  • [50] MicroRNAs and dendritic cell-based vaccination in melanoma patients
    De Rosa, Francesco
    Fanini, Francesca
    Guidoboni, Massimo
    Vannini, Ivan
    Amadori, Dino
    Ridolfi, Ruggero
    Ridolfi, Laura
    Fabbri, Muller
    MELANOMA RESEARCH, 2014, 24 (03) : 181 - 189
12345